Comment on National Youth Tobacco Survey (Docket No. FDA-2026-N-3070)

We were pleased to see the NYTS 2024 and 2025 data released in March 2026, and that FDA is now inviting public comments on future NYTS data collections.

As noted in our prior comments on NYTS when the survey was under the purview of the Centers for Disease Control and Prevention (CDC), we emphasize the importance and value of NYTS in tracking adolescent tobacco use behavior, which is crucial to the Agency in making its determinations that the authorization of noncombusted nicotine products, including e-cigarettes, are ‘Appropriate for the Protection of Public Health’ (APPH), which requires that the benefits to adults who smoke outweigh the risks to unintended populations including adolescents – the latter of which is informed to a significant extent by NYTS.

Read our full comment: https://www.pinneyassociates.com/wp-content/uploads/2026/10/Pinney-Associates-Comment-National-Youth-Tobacco-Survey-Docket-No.-FDA-2026-N-3070.pdf